Skip to main content
Caplight Logo









EV Therapeutics

EV Therapeutics

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.evtherapeutics.com/

Last Round

Accelerator

Sep 20, 2023

Momentum

Top 25%

of companies Caplight tracks

Company Overview

EV Therapeutics is a biotechnology company developing off-the-shelf neoantigen-based immunotherapies from tumor-derived extracellular vesicles to treat advanced-stage cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

immuno-oncologycancer vaccineextracellular vesiclestherapeutic cancer vaccinecancer immunotherapymTEVscolorectal cancerexosome therapyneoantigen deliverycheckpoint inhibitor resistanceI-Opre-clinical biotechMSS colorectal cancerdrug discovery platformbiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EV Therapeutics Comparables

Compare EV Therapeutics with similar companies based on industry and business-model similarity.

EV Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vanquish Bio
80%
UbiVac, Inc.
79%
EviCure
77%

EV Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorSep 20, 2023
AngelJul 1, 2020

Key People

Founding team and executive leadership

SUBREE SUBRAMANIAN

Chief Scientific Officer And Co-founder

Founding Team

EV Therapeutics Investors

Notable investors and investment history

EV Therapeutics investors
InvestorRounds
University of MinnesotaAngel
California Life SciencesAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors grew 278% MoM.

  • Jan 8, 2026

    Monthly visitors grew 96% MoM.

EV Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EV Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EV Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range2
Year Founded2020
Last FundingSep 20, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?